Cargando…
β cell responses to inflammation
BACKGROUND: The extended and clinically silent progression of Type 1 diabetes (T1D) creates a challenge for clinical interventions and for understanding the mechanisms that underlie its pathogenesis. Over the course of the development of Type 1 diabetes, studies in animal models and of human tissues...
Autores principales: | Usmani-Brown, Sahar, Perdigoto, Ana Luisa, Lavoie, Nathalie, Clark, Pamela, Korah, Maria, Rui, Jinxiu, Betancur, Gabriel, Herold, Kevan C. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6768505/ https://www.ncbi.nlm.nih.gov/pubmed/31500821 http://dx.doi.org/10.1016/j.molmet.2019.06.013 |
Ejemplares similares
-
Tet2 Controls the Responses of β cells to Inflammation in Autoimmune Diabetes
por: Rui, Jinxiu, et al.
Publicado: (2021) -
The receptor for advanced glycation endproducts (RAGE) modulates T cell signaling
por: Reed, James C., et al.
Publicado: (2020) -
Inducing and Administering Tregs to Treat Human Disease
por: Perdigoto, Ana Luisa, et al.
Publicado: (2016) -
Unmethylated Insulin as an Adjunctive Marker of Beta Cell Death and Progression to Type 1 Diabetes in Participants at Risk for Diabetes
por: Simmons, Kimber M., et al.
Publicado: (2019) -
Response to "NLRC5 germline variants and their potential role in eliciting an immune response in patients with cancer treated with immune checkpoint inhibitors" by Xiang-Yu Meng
por: Aizenbud, Lilach, et al.
Publicado: (2023)